CHICAGO CAPITAL, LLC – Ligand Pharmaceuticals Incorporated Transaction History
CHICAGO CAPITAL, LLC portfolio value:
$39.55M
portfolio value
CHICAGO CAPITAL, LLC quarter portfolio value change:
-3.49%
quarter
Ligand Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +2.44% | 10.95K shares | -451K | $86.11 | 459.31K |
| Q2 2022 | share | Decrease | -8.82% | -43.35K shares | -15.31M | $89.22 | 448.36K |
| Q1 2022 | share | Increase | +12.66% | 55.26K shares | -12.10M | $112.49 | 491.71K |
| Q4 2021 | share | Decrease | -0.87% | -3.82K shares | 6.07M | $156.16 | 436.45K |
| Q3 2021 | share | Decrease | -4.07% | -18.67K shares | 1.13M | $139.32 | 440.28K |
| Q2 2021 | share | Increase | +2.30% | 10.31K shares | -8.18M | $131.19 | 458.95K |
| Q1 2021 | share | Increase | +34.78% | 115.78K shares | 35.29M | $152.45 | 448.63K |
| Q4 2020 | share | Decrease | -31.49% | -152.98K shares | -13.20M | $99.45 | 332.85K |
| Q3 2020 | share | Increase | +80.77% | 217.08K shares | 16.24M | $95.32 | 485.84K |
| Q2 2020 | share | Increase | 0.00% | 268.76K shares | 30.06M | $111.85 | 268.76K |